vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and NOODLES & Co (NDLS). Click either name above to swap in a different company.
NOODLES & Co is the larger business by last-quarter revenue ($122.1M vs $77.6M, roughly 1.6× Bioceres Crop Solutions Corp.). NOODLES & Co runs the higher net margin — -7.5% vs -9.6%, a 2.1% gap on every dollar of revenue. On growth, NOODLES & Co posted the faster year-over-year revenue change (-4.1% vs -16.8%). Over the past eight quarters, NOODLES & Co's revenue compounded faster (-1.2% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
Noodles & Company is an American fast-casual restaurant that offers international and American noodle dishes in addition to soups and salads. Noodles & Company was founded in 1995 by Aaron Kennedy and is headquartered in Broomfield, Colorado. The company went public in 2013 and recorded a $457 million revenue in 2017. In mid-2022, there were 458 Noodles & Company locations across 31 states.
BIOX vs NDLS — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $122.1M |
| Net Profit | $-7.4M | $-9.2M |
| Gross Margin | 46.8% | — |
| Operating Margin | 9.3% | -5.2% |
| Net Margin | -9.6% | -7.5% |
| Revenue YoY | -16.8% | -4.1% |
| Net Profit YoY | -20.2% | 32.8% |
| EPS (diluted) | $-0.12 | $-0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $77.6M | $122.1M | ||
| Q2 25 | — | $123.8M | ||
| Q1 25 | $60.6M | — | ||
| Q4 24 | $98.8M | $122.8M | ||
| Q3 24 | $93.3M | $127.4M | ||
| Q2 24 | — | $121.4M | ||
| Q1 24 | $84.0M | $124.3M | ||
| Q4 23 | $140.2M | $127.9M |
| Q3 25 | $-7.4M | $-9.2M | ||
| Q2 25 | — | $-9.1M | ||
| Q1 25 | $-1.6M | — | ||
| Q4 24 | $605.2K | $-6.8M | ||
| Q3 24 | $-6.2M | $-13.6M | ||
| Q2 24 | — | $-6.1M | ||
| Q1 24 | $9.8M | $-6.1M | ||
| Q4 23 | $1.2M | $700.0K |
| Q3 25 | 46.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 39.4% | — | ||
| Q4 24 | 42.0% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 50.8% | — | ||
| Q4 23 | 36.7% | — |
| Q3 25 | 9.3% | -5.2% | ||
| Q2 25 | — | -5.2% | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 14.5% | -3.9% | ||
| Q3 24 | 2.5% | -9.0% | ||
| Q2 24 | — | -3.4% | ||
| Q1 24 | 15.7% | -3.7% | ||
| Q4 23 | 12.0% | 1.6% |
| Q3 25 | -9.6% | -7.5% | ||
| Q2 25 | — | -7.3% | ||
| Q1 25 | -2.6% | — | ||
| Q4 24 | 0.6% | -5.5% | ||
| Q3 24 | -6.6% | -10.7% | ||
| Q2 24 | — | -5.1% | ||
| Q1 24 | 11.6% | -4.9% | ||
| Q4 23 | 0.9% | 0.5% |
| Q3 25 | $-0.12 | $-0.20 | ||
| Q2 25 | — | $-0.20 | ||
| Q1 25 | $-0.02 | — | ||
| Q4 24 | $0.00 | $-0.15 | ||
| Q3 24 | $-0.10 | $-0.30 | ||
| Q2 24 | — | $-0.14 | ||
| Q1 24 | $0.14 | $-1.64 | ||
| Q4 23 | $0.00 | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $4.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $288.3M | $-38.9M |
| Total Assets | $734.9M | $280.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $15.5M | $4.7M | ||
| Q2 25 | — | $1.4M | ||
| Q1 25 | $38.5M | — | ||
| Q4 24 | $29.2M | $3.3M | ||
| Q3 24 | $32.3M | $1.8M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | $16.4M | $3.0M | ||
| Q4 23 | $24.4M | $2.5M |
| Q3 25 | $288.3M | $-38.9M | ||
| Q2 25 | — | $-13.9M | ||
| Q1 25 | $345.0M | — | ||
| Q4 24 | $346.3M | $3.7M | ||
| Q3 24 | $346.0M | $9.6M | ||
| Q2 24 | — | $21.9M | ||
| Q1 24 | $348.5M | $27.2M | ||
| Q4 23 | $335.3M | $32.5M |
| Q3 25 | $734.9M | $280.6M | ||
| Q2 25 | — | $319.4M | ||
| Q1 25 | $798.2M | — | ||
| Q4 24 | $835.2M | $340.5M | ||
| Q3 24 | $827.3M | $346.3M | ||
| Q2 24 | — | $360.4M | ||
| Q1 24 | $836.1M | $368.1M | ||
| Q4 23 | $819.5M | $368.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $4.3M |
| Free Cash FlowOCF − Capex | — | $-2.8M |
| FCF MarginFCF / Revenue | — | -2.3% |
| Capex IntensityCapex / Revenue | — | 5.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-7.5M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $14.4M | $4.3M | ||
| Q2 25 | — | $4.0M | ||
| Q1 25 | $23.3M | — | ||
| Q4 24 | $-5.4M | $5.8M | ||
| Q3 24 | $5.2M | $4.7M | ||
| Q2 24 | — | $7.0M | ||
| Q1 24 | $-17.4M | $164.0K | ||
| Q4 23 | $21.1M | $16.9M |
| Q3 25 | — | $-2.8M | ||
| Q2 25 | — | $1.1M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | — | $-4.5M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $-15.2M | ||
| Q4 23 | — | $4.1M |
| Q3 25 | — | -2.3% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -1.1% | ||
| Q3 24 | — | -3.5% | ||
| Q2 24 | — | -1.4% | ||
| Q1 24 | — | -12.2% | ||
| Q4 23 | — | 3.2% |
| Q3 25 | — | 5.8% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | — | 7.1% | ||
| Q1 24 | — | 12.3% | ||
| Q4 23 | — | 10.0% |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -8.85× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.78× | — | ||
| Q4 23 | 17.05× | 24.21× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOX
Segment breakdown not available.
NDLS
| Food And Beverage | $119.6M | 98% |
| Franchise | $2.5M | 2% |
